Skip to main content

Month: June 2021

CVG to Join Russell 2000® Index

NEW ALBANY, Ohio, June 28, 2021 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI) announced that as part of the annual reconstitution of the Russell stock indexes, CVG has been selected to be added to the Russell 2000® index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens today, June 28, 2021. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 7, 2021, ranking them by total market capitalization. Membership in the Russell 2000®, Russell 3000® and Russell Microcap® indexes, which remains in place for one year, means automatic inclusion in appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Harold Bevis, President and Chief...

Continue reading

Punjab National Bank (PNB) Selects EbixCash to Operate and Manage Its Country Wide Enterprise Wide Area Network Across India for the Next 3 Years

NOIDA, India and JOHNS CREEK, Ga., June 28, 2021 (GLOBE NEWSWIRE) — EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced that India’s second largest Government owned bank – Punjab National Bank (PNB), has selected EbixCash as its Network Integrator (NI) for desgning,, monitoring and managing its Enterprise Wide Area Network (EWAN) across India for a period of 3 years beginning July 1, 2021. The agreement involves the deployment of 1000+ dedicated EbixCash employees to assess, optimize and manage the EWAN, Data Center and Disaster Recovery Sites (DRS) spread pan-India across the PNB headquarters, 24 zonal offices , 161 circle offices and 16,250 branches. With...

Continue reading

Ceylon Graphite Announces Publication in the Royal Society

VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon Graphite”) (TSX-V:CYL)(OTC:CYLYF)(FSE:CCY) is pleased to announce Ceylon Chief Scientific Executive, Dr. Siva Bohm, and Ceylon Technical Director Dr. Mallika Bohm have published a paper titled “Graphene Production By Cracking” in one of the oldest Journal by the Royal Society, “Philosophical Transaction A”. This follows a long list of publications By Drs. Bohm. The Abstract from the Paper reads as follows: “In recent years, graphene has found its use in numerous industrial applications due to its unique properties. While its impermeable and conductive nature can replace currently used anticorrosive toxic pigments in coating systems, due to its large strength to weight ratio, graphene can be an important component as a next-generation additive...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – ULTRA ELECTRONICS HOLDINGS PLC – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Radisson Hotel Group expands presence in Turkey with new hotel in Izmir, Aliaga

Radisson Hotel Izmir Aliaga lobbyRadisson Hotel Izmir Aliaga lobbyRadisson Hotel Group expands presence in Turkey with new hotel in Izmir, Aliaga Radisson Hotel Group is proud to announce the opening of Radisson Hotel Izmir Aliaga and welcome guests to one of Turkey’s key ports and gateway to Izmir, the pearl of the Aegean Sea. The opening of the hotel strengthens the brand’s presence in Turkey and brings the Group’s portfolio across the country to over 31 hotels in operation and under development.Radisson Hotel Izmir Aliaga features 185 rooms and suites equipped with individual desks or work areas, free high-speed Wi-Fi, and a wide range of amenities such as in-room coffee and tea facilities, together with bathrobe and slippers to make guests as comfortable as possible. With small personal touches that go a long way,...

Continue reading

Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings

Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings DUBLIN, Ireland, and Boston MA, 28 June 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases (the “Company” or “Amryt”), is pleased to announce that:further to the Company’s announcement on 5 May 2021 in relation to the proposed acquisition of Chiasma, Inc. (“Chiasma” and the proposed acquisition being the “Transaction”), a circular (the “Circular”) containing notice of a general meeting to be held at the Company’s headquarters at 45 Mespil Road, Dublin 4, Ireland at 2:00 p.m. on 28 July 2021, (the “Transaction General Meeting”) concerning the Transaction...

Continue reading

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression

COMPASS on track to report data in late 2021 London, UK, June 28, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has completed psilocybin administration to the target 216 patients in its phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression. This is the world’s largest psilocybin therapy trial to date. The trial is a randomised controlled, double-blinded, dose-ranging study, investigating the safety and efficacy of psilocybin therapy and comparing a 25mg and 10mg dose of COMP360 psilocybin with a 1mg dose, administered in conjunction with psychological support from specially trained therapists. The 216th patient in the trial had...

Continue reading

Results of the 2021 Annual General Meeting

June 28, 2021 | SAINT HELIER, Jersey – — CoinShares (Nasdaq First North Growth Market: CS), Europe’s largest digital asset investment firm, today held its Annual General Meeting (the “AGM”). Due to the continuing pandemic, the AGM was held only through postal voting in accordance with temporary legislation. Resolution 5 – Resolution to adopt the income statement, balance sheet, consolidated income statement and consolidated balance sheetThe AGM resolved that the income statement, balance sheet, consolidated income statement and consolidated balance sheet be adopted by the Company. Resolutions 6, 7 and 8 – Election of Directors and Auditors, and fees to the AuditorsThe AGM resolved to re-elect Daniel Masters, Jean-Marie Mognetti, Carsten Køppen and John Lundberg as members of the Board. The AGM further resolved to re-elect...

Continue reading

EyePoint Pharmaceuticals Joins Russell 2000® and Russell 3000® Index

WATERTOWN, Mass., June 28, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced today that the Company will be added to the small-cap Russell 2000® Index and the broad-market Russell 3000® Index effective after the US market opens on June 28, 2021 as a result of the annual Russell index reconstitution. The Russell 2000® Index measures the performance of the small-cap segment of the US equity market. The Russell 2000® Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes the securities of approximately 2,000 smaller companies, based on their market capitalization rankings and...

Continue reading

JOANN set to join Russell 2000® Index

HUDSON, Ohio, June 28, 2021 (GLOBE NEWSWIRE) — JOANN Inc. (NASDAQ: JOAN) (“JOANN”), the nation’s category leader in sewing and one of the fastest growing competitors in the arts and crafts category, announced that it has formally joined the Russell 2000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28. Membership in the Russell 2000® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are pleased to be part of the Russell 2000® following our recent listing on NASDAQ,” said Wade Miquelon, President and Chief Executive Officer of JOANN. “The inclusion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.